Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related DSW
Top 4 Mid-Cap Stocks In The Apparel Stores Industry With The Lowest PEG Ratio
Footwear Pair Trades From Morgan Stanley; UGG Boots Are A 'Top Holiday Gift'
Making Money With Charles Payne: 12/30/14 (Fox Business)
Related PFE
The 5 Best Dow Stocks So Far In 2015
Pfizer Warns U.K. Doctors About Prescribing Generic Lyrica For Pain
Week Ahead: Busy Economic Calender with FOMC, Earnings (Fox Business)

Analysts at Sterne Agee downgraded DSW (NYSE: DSW) from Neutral to Underperform. The target price for DSW is set to $23. DSW's shares closed at $27.16 on Friday.

BMO Capital downgraded Pfizer (NYSE: PFE) from Outperform to Market Perform. The target price for Pfizer has been lowered from $34 to $31. Pfizer's shares closed at $30.19 on Friday.

Analysts at Canaccord Genuity downgraded AcelRx Pharmaceuticals (NASDAQ: ACRX) from Buy to Hold. The target price for AcelRx Pharmaceuticals has been lowered from $16.00 to $8.00. AcelRx Pharmaceuticals' shares closed at $10.83 on Friday.

Deutsche Bank downgraded Lear (NYSE: LEA) from Buy to Hold. The target price for Lear has been raised from $100.00 to $103.00. Lear's shares closed at $99.00 on Friday.

Latest Ratings for DSW

DateFirmActionFromTo
Nov 2014CitigroupMaintainsBuy
Nov 2014Credit SuisseMaintainsOutperform
Nov 2014Sterne AgeeUpgradesUnderperformNeutral

View More Analyst Ratings for DSW
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (DSW + ACRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional